EMMPRIN mediates β-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes
- 31 January 2008
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 44 (1) , 210-217
- https://doi.org/10.1016/j.yjmcc.2007.07.054
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in miceJournal of Clinical Investigation, 2005
- Reduction of myocardial infarct size by doxycycline: A role for plasmin inhibitionMolecular and Cellular Biochemistry, 2005
- Early Short-Term Treatment With Doxycycline Modulates Postinfarction Left Ventricular RemodelingCirculation, 2003
- A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart FailureCirculation, 2000
- Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failureNature Medicine, 1999
- Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement After Experimental Myocardial Infarction in MiceCirculation, 1999
- Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human HeartCirculation, 1998
- Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated CardiomyopathyCirculation, 1998
- Differential gene expression of extracellular matrix components in dilated cardiomyopathyJournal of Cellular Biochemistry, 1996
- Post-transcriptional Regulation of Extracellular Matrix Metalloproteinase in Human Heart End-stage Failure Secondary to Ischemic CardiomyopathyJournal of Molecular and Cellular Cardiology, 1996